Biogen expects impending biosimilar launches to stimulate new growth, while unfavorable market conditions have taken their toll on the company.
Outgoing Biogen CEO Michel Vounatsos told investors that the company believes new launches of biosimilars have the potential to drive renewed growth, particularly its “gradual” Byooviz (ranibizumab-nuna) launch, which is expected to make a more meaningful contribution to its revenue from 2023.
The biosimilars business, alongside wider near-term opportunities for Biogen, “have the potential to drive renewed growth and position us to...
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
